Mycenax Biotech Inc. (TPEX:4726)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.25
+0.15 (0.52%)
Apr 29, 2026, 1:30 PM CST

Mycenax Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
224.55269.57519.271,323286.93
Upgrade
Short-Term Investments
-7.3148.4216.12-
Upgrade
Cash & Short-Term Investments
224.55276.87667.691,339286.93
Upgrade
Cash Growth
-18.90%-58.53%-50.15%366.84%-1.45%
Upgrade
Accounts Receivable
130.88140.7458.5381.32320.84
Upgrade
Other Receivables
8.127.734.693.0911.33
Upgrade
Receivables
139148.4763.2284.41332.17
Upgrade
Inventory
132.8964.94112.33246.72173.3
Upgrade
Prepaid Expenses
57.4971.4583.25103.2289.28
Upgrade
Other Current Assets
222.1174.66171.53149.9515.73
Upgrade
Total Current Assets
776.02736.381,0981,924897.41
Upgrade
Property, Plant & Equipment
1,5771,7051,8471,9781,351
Upgrade
Long-Term Investments
155.56177.87190.81199.51109.59
Upgrade
Goodwill
23.9223.9223.9223.9223.92
Upgrade
Other Intangible Assets
17.2112.3418.9825.9333.71
Upgrade
Long-Term Deferred Tax Assets
101.0698.695.4989.7281.11
Upgrade
Other Long-Term Assets
610.8614.67495.85211.93642.46
Upgrade
Total Assets
3,2613,3683,7704,4533,139
Upgrade
Accounts Payable
77.4734.6344.0552.5254.68
Upgrade
Accrued Expenses
102.9698.05112.32104.2196.4
Upgrade
Short-Term Debt
280--10050
Upgrade
Current Portion of Long-Term Debt
196.55168.08125.92105.8815.6
Upgrade
Current Portion of Leases
39.2131.9230.5737.2828.59
Upgrade
Current Unearned Revenue
361.69230.85187.28142.28152.12
Upgrade
Other Current Liabilities
48.1997.97253.2892.57142.69
Upgrade
Total Current Liabilities
1,106661.5753.42634.73540.07
Upgrade
Long-Term Debt
433.67611.37530.4656.32474.4
Upgrade
Long-Term Leases
122.4672.0439.3956.37176.06
Upgrade
Long-Term Deferred Tax Liabilities
----3.75
Upgrade
Other Long-Term Liabilities
----38.07
Upgrade
Total Liabilities
1,6621,3451,3231,3471,232
Upgrade
Common Stock
2,0722,0702,0592,0531,533
Upgrade
Additional Paid-In Capital
67.32421.111,0741,468576.95
Upgrade
Retained Earnings
-540.63-466.91-682.64-406.83-254.34
Upgrade
Comprehensive Income & Other
0.04-0.79-3.32-8.850.72
Upgrade
Shareholders' Equity
1,5992,0232,4473,1061,907
Upgrade
Total Liabilities & Equity
3,2613,3683,7704,4533,139
Upgrade
Total Debt
1,072883.39726.28955.85744.64
Upgrade
Net Cash (Debt)
-847.35-606.53-58.59383.63-457.72
Upgrade
Net Cash Per Share
-4.09-2.94-0.292.32-3.08
Upgrade
Filing Date Shares Outstanding
207.23207.01205.89205.31153.33
Upgrade
Total Common Shares Outstanding
207.23207.01205.89205.31153.33
Upgrade
Working Capital
-330.0474.89344.591,289357.34
Upgrade
Book Value Per Share
7.729.7711.8915.1312.43
Upgrade
Tangible Book Value
1,5581,9872,4043,0561,849
Upgrade
Tangible Book Value Per Share
7.529.6011.6814.8812.06
Upgrade
Buildings
819.36792.86792.86791.68-
Upgrade
Machinery
1,5971,5941,6031,575837.57
Upgrade
Construction In Progress
165.54158.09106.853.35624.35
Upgrade
Leasehold Improvements
325.48325.53317.34307.77276.23
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.